Comparison of Single- and Double-Level Radiofrequency Ablation for Chronic Coccydynia
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aims to compare two commonly used radiofrequency ablation (RFA) techniques for the treatment of chronic tailbone (coccyx) pain, also known as coccydynia. Chronic coccydynia can significantly impair daily activities and reduce quality of life, particularly in patients who do not respond adequately to conservative treatments. Participants in this study will be randomly assigned to receive either a single-level or double-level radiofrequency ablation (RFA) procedure targeting the coccygeal nerve pathways. These procedures are minimally invasive and are routinely performed in pain management practice. The primary objective of the study is to determine which technique provides superior pain relief and functional improvement. Patients will be followed for up to two months after the procedure, and pain intensity and quality of life will be evaluated using validated outcome measures. The results of this study may help optimize interventional treatment strategies for patients suffering from chronic coccydynia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2026
CompletedFirst Posted
Study publicly available on registry
April 3, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
July 9, 2026
July 1, 2026
1 year
March 29, 2026
July 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in pain intensity (Numeric Rating Scale, NRS)
Pain intensity will be assessed using the Numeric Rating Scale (NRS), a self-reported scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain scores from baseline will be evaluated at 1 hour, 3 weeks, and 2 months after the procedure. Higher scores indicate worse pain intensity.
Baseline, 1 hour, 3 weeks, and 2 months post-procedure
Secondary Outcomes (2)
Quality of life (EuroQol-5D-3L, EQ-5D-3L)
Baseline, 3 weeks, and 2 months post-procedure
Functional status (Paris Coccydynia Questionnaire)
Baseline, 3 weeks, and 2 months post-procedure
Study Arms (2)
Single-Level Radiofrequency Ablation
ACTIVE COMPARATORParticipants in this arm will undergo fluoroscopy-guided single-level radiofrequency ablation of the ganglion impar using a standardized technique. The procedure will be performed under sterile conditions by experienced pain specialists.
Double-Level Radiofrequency Ablation
ACTIVE COMPARATORParticipants in this arm will undergo fluoroscopy-guided double-level radiofrequency ablation of the ganglion impar, targeting two adjacent levels using a standardized technique. The procedure will be performed under sterile conditions by experienced pain specialists.
Interventions
Fluoroscopy-guided radiofrequency ablation of the ganglion impar will be performed using a transsacrococcygeal approach. After appropriate needle placement and confirmation, thermal radiofrequency lesioning will be applied at a single level using standardized parameters.
Fluoroscopy-guided radiofrequency ablation of the ganglion impar will be performed using a combined transsacrococcygeal and transcoccygeal approach. After appropriate needle placement and confirmation, thermal radiofrequency lesioning will be applied at two adjacent levels using standardized parameters.
Eligibility Criteria
You may qualify if:
- Patients with coccygeal pain lasting longer than 2 months
- Patients who experienced significant pain relief (≥50% reduction) after a ganglion impar block performed within the last 6 months, but whose pain has subsequently recurred
- Patients who provide informed consent to participate in the study
You may not qualify if:
- Acute coccydynia (pain duration less than 2 months)
- Patients who did not achieve significant benefit (\<50% pain reduction) from prior ganglion impar block
- Patients with severe neurological or psychiatric disorders that impair communication or ability to follow instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University Faculty of Medicine
Istanbul, PENDİK, 34899, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD
Study Record Dates
First Submitted
March 29, 2026
First Posted
April 3, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
July 9, 2026
Record last verified: 2026-07